SCHEMBL1070595

SCHEMBL1070595

C=C(c1ccccc1)c1ccc(O[Si](C)(C)C(C)(C)C)c(O[Si](C)(C)C(C)(C)C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.39
MEN1 O00255 1/20 0.39
DRD2 P14416 1/20 0.38
PDE4A P27815 3/20 0.38
PDE4B Q07343 3/20 0.38
PDE4C Q08493 3/20 0.38
PDE4D Q08499 3/20 0.38
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36
TUBA3C P0DPH7 1/20 0.36
TUBA1B P68363 1/20 0.36
TUBA4A P68366 1/20 0.36
TUBB4B P68371 1/20 0.36
TUBB3 Q13509 1/20 0.36
TUBB2A Q13885 1/20 0.36
TUBB8 Q3ZCM7 1/20 0.36
TUBA3E Q6PEY2 1/20 0.36
TUBA1A Q71U36 1/20 0.36
TUBA1C Q9BQE3 1/20 0.36
TUBB6 Q9BUF5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3668334 0.82 CYP1A2 (0.52) ELANECYP1A2CYP2D6HPGDCYP2C19
SCHEMBL6524959 0.81 MEN1 (0.43) KMT2AMEN1ELANETDP1
SCHEMBL12677608 0.79 TUBB4A (0.59) DRD2PDE4APDE4BPDE4CPDE4D
SCHEMBL5052728 0.79 ELANE (0.38) KMT2AMEN1DRD2ELANEHPGD
SCHEMBL8940576 0.78 CA12 (0.51) DRD2HPGD
SCHEMBL9170217 0.78 PDE4A (0.53) KMT2AMEN1PDE4APDE4BPDE4C
SCHEMBL12574107 0.76 PDE4A (0.48) DRD2PDE4APDE4BPDE4CPDE4D
SCHEMBL2281109 0.74 MEN1 (0.39) KMT2AMEN1
SCHEMBL25189253 0.74 PREP (0.43) KMT2AMEN1DRD2PDE4APDE4B
SCHEMBL9688347 0.74 DRD2 (0.40) DRD2PDE4DCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2448980-B1 POLYMERS FUNCTIONALIZED WITH HYDROXYL GROUP-CONTAINING DIPHENYLETHYLENE BRIDGESTONE CORP (JP) 2015-02-11 EP disclosed
US-8765888-B2 Polymers functionalized with hydroxyl group-containing diphenylethylene BRIDGESTONE CORPORATION (JP) 2014-07-01 US disclosed
US-20120130009-A1 POLYMERS FUNCTIONALIZED WITH HYDROXYL GROUP-CONTAINING DIPHENLYETHYLENE BRIDGESTONE CORPORATION (JP) 2012-05-24 US disclosed
EP-2448980-A2 POLYMERS FUNCTIONALIZED WITH HYDROXYL GROUP-CONTAINING DIPHENYLETHYLENE Bridgestone Corporation (JP) 2012-05-09 EP disclosed
WO-2011002830-A2 POLYMERS FUNCTIONALIZED WITH HYDROXYL GROUP-CONTAINING DIPHENYLETHYLENE BRIDGESTONE CORPORATION (JP) 2011-01-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120130009-A1 POLYMERS FUNCTIONALIZED WITH HYDROXYL GROUP-CONTAINING DIPHENLYETHYLENE VCL, PGR, CD44 KMT2A 2411/4885MEN1 4176/4885DRD2 844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.